The Recall Desk
HighFDA (Drugs)·D-0241-2026·Announced 2025-12-31

Aprepitant oral suspension kits recalled over potential metal particulates

Merck Sharp & Dohme is recalling 3 single-dose kits of Emend (aprepitant) for oral suspension over the potential presence of metal particulates in the product.

What this means for you

Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.

Our severity reasoning: Scored 3 under the risk-of-harm criterion: metal particulates in an oral medicine are a stated physical contaminant, and no injuries are reported.

Plain-English summary

Merck Emend (aprepitant) for oral suspension, 125 mg, single-dose kit, manufactured by Novo Nordisk Production Ireland Limited of Athlone, Ireland for Merck Sharp & Dohme LLC of Rahway, New Jersey, under NDC 0006-3066-03, is being recalled.

The reason given in the enforcement record is the presence of particulate matter: the potential presence of metal particulates in the product.

The recall covers 3 single-dose kits from lot Z014503, expiry 11/15/2027. Distribution was nationwide in the USA. The FDA has classified the action as Class II.

Patients should not stop taking a prescribed medicine without speaking to their prescriber or pharmacist, who can confirm whether a specific kit is affected and arrange a replacement.

The recalled product

Product
EMEND (APREPITANT)
Brand
EMEND
Manufacturer
Merck Sharp & Dohme LLC
Hazard
  • particulate-matter
  • metal-particulates
  • contamination

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (2)

  • Lot #: Z014503
  • Exp 11/15/2027

Distribution

Distributed nationwide across the United States.